Waverley Pharma Inc V.WAVE

Healthcare Biotechnology

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution agreement with Reliance Life Sciences Private Limited, which has granted it an exclusive territorial license to market and sell capecitabine in the UK and Germany as well as a non-exclusive territorial license to market and sell temozolomide and erlotinib in the UK. Its generic oncology products include bortezomib and pemetrexed. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma.

TSXV:WAVE - Post by User

Waverley Pharma Inc > Waverley Pharma Announces Tentative ANDA Approval for Pemetr

<< Previous

Bullboard Posts

Next >>

Comment by Jericomileon Nov 16, 2020 3:28pm

113 Views

Post# 31908276

RE:RE:RE:RE:RE:RE:Waverley Pharma Announces Tentative ANDA Approval for Pemetr

One person from RBC sold over 90K, lacks patience or wants to take a loss and move onto something else. If you feel you may lose all your money, cut your losses and invest in another company. Personally, I doubt you will lose your money. It all comes down to your comfort zone.

<< Previous

Bullboard Posts

Next >>

Global Tungsten Market and Supply Security